BPC-157 + Thymosin Beta-4 (TB-500) 5 mg + 5 mg — Certificate of Analysis — 12/08/2025

Compound	BPC-157 + Thymosin Beta-4 (TB-500)
Strength / claim	5 mg + 5 mg
Report type	Certificate of Analysis
Report ID	Pending Review
Issued	Pending Review
Tested	12/08/2025
Laboratory	N/A
Purity	99.128%
Reported content	5mg

Open PDF report

Blend identity is clear in the source certificate, but strength differs from the current 10 mg + 10 mg product.

Published for research documentation and batch-reference purposes. Laboratory results are not therapeutic or clinical evidence.